Laxxon Medical Announces Formation of Scientific Advisory Board with Renowned Pharmaceutical Experts
- May 25, 2023
- 3 min
Overcoming Regulatory Challenges In 3D Printing of Pharmaceuticals
- May 8, 2023
- 3 min
10 Strategies for Improving Patient Experience
- May 1, 2023
- 4 min
Laxxon Medical's Commitment to Meeting and Exceeding CGMP Regulations In 3D Printed Pharmaceuticals
- Apr 6, 2023
- 2 min
CSO Achim Schneeberger Discusses the Development of Laxxon's Levodopa Project
- Apr 5, 2023
- 2 min
CEO Helmut Kerschbaumer discusses Laxxon's Partnership with Hovione
- Apr 4, 2023
- 3 min
Methods to Reduce Patient Anxiety
- Mar 28, 2023
- 4 min
Interview with Laxxon COO Klaus Kuehne
- Mar 24, 2023
- 3 min
Women In Science – Celebrating Women’s History Month
- Mar 23, 2023
- 3 min
Hovione and Laxxon Medical Partnership Announced
- Mar 3, 2023
- 4 min
Why are Adverse Drug Reactions Doubled in Women?
- Feb 24, 2023
- 3 min
Digital Communication and Patient Experience
- Feb 3, 2023
- 5 min
3-Dimensional Screen Printing of Pharmaceuticals
- Dec 9, 2022
- 4 min
The “Freezing of Gait” Effect From Levodopa Management of Parkinson Disease
- Dec 2, 2022
- 2 min
Pharma Tech News & Development
- Nov 25, 2022
- 3 min
Evonik & Laxxon: An Innovative Force
- Nov 21, 2022
- 4 min
A Video Interview with Laxxon Leadership
- Nov 18, 2022
- 5 min
An Interview with Helmut Kerschbaumer, Chief Executive Officer at Laxxon Medical
- Nov 4, 2022
- 8 min
What Is Medical 3D Printing and How Is it Regulated?
- Oct 21, 2022
- 3 min
What Are Advanced Patented Generics?